Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T07:24:54.627Z Has data issue: false hasContentIssue false
  • English
  • Français

Characteristics and outcomes of acute COVID-19 infection in paediatric and young adult patients with underlying cardiac disease

Part of: Infectious

Published online by Cambridge University Press:  30 September 2021

Joshua M. Fisher ,
Sarah Badran ,
John T. Li ,
Jodie K. Votava-Smith  and
Patrick M. Sullivan Open the ORCID record for Patrick M. Sullivan [Opens in a new window]
Joshua M. Fisher
Affiliation:
Division of General Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, USA
Sarah Badran
Affiliation:
Department of Pediatrics, Children’s Hospital Los Angeles Heart Institute, Los Angeles, CA, USA
John T. Li
Affiliation:
Department of Anesthesia and Critical Care Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA
Jodie K. Votava-Smith
Affiliation:
Department of Pediatrics, Children’s Hospital Los Angeles Heart Institute, Los Angeles, CA, USA
Patrick M. Sullivan*
Affiliation:
Department of Pediatrics, Children’s Hospital Los Angeles Heart Institute, Los Angeles, CA, USA
*
Author for correspondence: Patrick M Sullivan, MD, Children’s Hospital Los Angeles Heart Institute, 4650 Sunset Blvd. #34 Los Angeles, CA 90027, USA. Tel: 323 361 6590; Fax: 323 361 1513. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

To describe outcomes of acute coronavirus disease 2019 in paediatric and young adult patients with underlying cardiac disease and evaluate the association between cardiac risk factors and hospitalisation.

Study design

We conducted a retrospective single-institution review of patients with known cardiac disease and positive severe acute respiratory syndrome coronavirus 2 RT-PCR from 1 March, 2020 to 30 November, 2020. Extracardiac comorbidities and cardiac risk factors were compared between those admitted for coronavirus disease 2019 illness and the rest of the cohort using univariate analysis.

Results

Forty-two patients with a mean age of 7.7 ± 6.7 years were identified. Six were 18 years of age or more with the oldest being 22 years of age. Seventy-six percent were Hispanic. The most common cardiac diagnoses were repaired cyanotic (n = 7, 16.6%) and palliated single ventricle (n = 7, 16.6%) congenital heart disease. Fourteen patients (33.3%) had underlying syndromes or chromosomal anomalies, nine (21%) had chronic pulmonary disease and eight (19%) were immunosuppressed. Nineteen patients (47.6%) reported no symptoms. Sixteen (38.1%) reported only mild symptoms. Six patients (14.3%) were admitted to the hospital for acute coronavirus disease 2019 illness. Noncardiac comorbidities were associated with an increased risk of hospitalisation (p = 0.02), particularly chronic pulmonary disease (p = 0.01) and baseline supplemental oxygen requirement (p = 0.007). None of the single ventricle patients who tested positive required admission.

Conclusions

Hospitalisations for coronavirus disease 2019 were rare among children and young adults with underlying cardiac disease. Extracardiac comorbidities like pulmonary disease were associated with increased risk of hospitalisation while cardiac risk factors were not.

Keywords

SARS-CoV-2COVID-19congenital heart diseasecardiovascular disease
Type
Original Article
Information
Cardiology in the Young , Volume 32 , Issue 8 , August 2022 , pp. 1261 - 1267
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cucinotta, D, Vanelli, M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91: 157–160.Google ScholarPubMed
He, J, Guo, Y, Mao, R, Zhang, J. Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol 2021; 93: 820–830.CrossRefGoogle ScholarPubMed
Tsabouri, S, Makis, A, Kosmeri, C, Siomou, E. Risk factors for severity in children with coronavirus disease 2019: a comprehensive literature review. Pediatr Clin North Am 2021; 68: 321–338.CrossRefGoogle ScholarPubMed
Lu, X, Zhang, L, Du, H, et al. SARS-CoV-2 infection in children. N Engl J Med 2020; 382: 1663–1665.CrossRefGoogle ScholarPubMed
Ludvigsson, JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109: 1088–1095.CrossRefGoogle Scholar
Parri, N, Magistà, AM, Marchetti, F, et al. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian pediatric research networks. Eur J Pediatr 2020; 179: 1315–1323.CrossRefGoogle ScholarPubMed
Kim, L, Whitaker, M, O'Halloran, A, etal, . Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1081–1088.CrossRefGoogle ScholarPubMed
Bixler, D, Miller, AD, Mattison, CP, et al. SARS-CoV-2-associated deaths among persons aged <21 years - United States, February 12-July 31, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1324–1329.CrossRefGoogle ScholarPubMed
Dong, Y, Mo, X, Hu, Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145: e20200702. doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16.CrossRefGoogle ScholarPubMed
Hoang, A, Chorath, K, Moreira, A, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine 2020; 24: 100433.CrossRefGoogle ScholarPubMed
Shekerdemian, LS, Mahmood, NR, Wolfe, KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020; 174: 1–6.CrossRefGoogle ScholarPubMed
Tan, W, Aboulhosn, J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020; 309: 70–77.CrossRefGoogle ScholarPubMed
Ouldali, N, Yang, DD, Madhi, F, et al. Factors associated with severe SARS-CoV-2 infection. Pediatrics 2021; 147: e2020023432.CrossRefGoogle ScholarPubMed
Araujo, JJ. Impact of the SARS-Cov-2 virus pandemic on children and adults with congenital heart disease: its burden and risk factors. Int J Clin Cardiol 2020; 7: 190. DOI 10.23937/2378-2951/1410190.Google Scholar
Zareef, RO, Younis, NK, Bitar, F, Eid, AH, Arabi, M. COVID-19 in pediatric patients: a focus on CHD patients. Front Cardiovasc Med 2020; 7: 612460. DOI 10.3389/fcvm.2020.612460.CrossRefGoogle ScholarPubMed
Ruan, Q, Yang, K, Wang, W, Jiang, L, Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive Care Med 2020; 46: 846–848.CrossRefGoogle Scholar
Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.CrossRefGoogle ScholarPubMed
Yang, J, Zheng, Y, Gou, X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–95.CrossRefGoogle ScholarPubMed
Sabatino, J, Ferrero, P, Chessa, M, et al. COVID-19 and congenital heart disease: results from a nationwide survey. J Clin Med 2020; 9: 1774.CrossRefGoogle ScholarPubMed
Lewis, MJ, Anderson, BR, Fremed, M, et al. Impact of coronavirus disease 2019 (COVID-19) on patients with congenital heart disease across the lifespan: the experience of an academic congenital heart disease center in New York City. J Am Heart Assoc 2020; 9: e017580.CrossRefGoogle ScholarPubMed
Kompaniyets, L, Agathis, NT, Nelson, JM, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open 2021; 4: e2111182.CrossRefGoogle ScholarPubMed
Cabalka, AK. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease. Pediatr Infect Dis J 2004, 23(1 Suppl):S41–S45.CrossRefGoogle Scholar
Tracking COVID-19 in California. Retrieved January 28, 2021, https://covid19.ca.gov/state-dashboard/.Google Scholar
Pan, W, Zhang, J, Wang, M, et al. Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients. Hypertension 2020; 76: 732–741.CrossRefGoogle ScholarPubMed